1. Home
  2. ELDN
  3. ELDN News

Latest Eledon Pharmaceuticals Inc. (ELDN) News on May 9, 2025

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) has caught the attention of institutional investors who hold a sizeable 46% stake
ELDN

Simply Wall St.

7 days ago

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) has caught the attention of institutional investors who hold a sizeable 46% stake

We're Hopeful That Eledon Pharmaceuticals (NASDAQ:ELDN) Will Use Its Cash Wisely
ELDN

Simply Wall St.

2 months ago

We're Hopeful That Eledon Pharmaceuticals (NASDAQ:ELDN) Will Use Its Cash Wisely

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
ELDN

GlobeNewswire

2 months ago

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
ELDN

GlobeNewswire

2 months ago

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
ELDN

GlobeNewswire

3 months ago

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference
ELDN

GlobeNewswire

3 months ago

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
ELDN

GlobeNewswire

4 months ago

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions
ELDN

Simply Wall St.

6 months ago

Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
ELDN

GlobeNewswire

6 months ago

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
ELDN

GlobeNewswire

6 months ago

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
ELDN

GlobeNewswire

6 months ago

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
ELDN

GlobeNewswire

6 months ago

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
ELDN

GlobeNewswire

8 months ago

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients
ELDN

GlobeNewswire

8 months ago

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results
ELDN

GlobeNewswire

9 months ago

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
ELDN

GlobeNewswire

9 months ago

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection

Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
ELDN

GlobeNewswire

10 months ago

Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
ELDN

GlobeNewswire

a year ago

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
ELDN

GlobeNewswire

a year ago

Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
ELDN

GlobeNewswire

a year ago

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress

Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
ELDN

GlobeNewswire

a year ago

Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection

Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
ELDN

GlobeNewswire

a year ago

Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
ELDN

GlobeNewswire

a year ago

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
ELDN

GlobeNewswire

a year ago

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
ELDN

GlobeNewswire

a year ago

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ELDN

GlobeNewswire

a year ago

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Celsius (NASDAQ:CELH): Strongest Q3 Results from the Beverages and Alcohol Group
ELDN

StockStory

a year ago

Celsius (NASDAQ:CELH): Strongest Q3 Results from the Beverages and Alcohol Group

We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely
ELDN

Simply Wall St.

a year ago

We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update
ELDN

Zacks

a year ago

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

Tiptree Inc.'s (NASDAQ:TIPT) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
ELDN

Simply Wall St.

a year ago

Tiptree Inc.'s (NASDAQ:TIPT) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

ZeroFox to Participate in 26th Annual Needham Growth Conference
ELDN

GlobeNewswire

a year ago

ZeroFox to Participate in 26th Annual Needham Growth Conference

Scholastic (NASDAQ:SCHL) Will Pay A Dividend Of $0.20
ELDN

Simply Wall St.

a year ago

Scholastic (NASDAQ:SCHL) Will Pay A Dividend Of $0.20

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
ELDN

GlobeNewswire

a year ago

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook

Relmada Therapeutics Provides Corporate Update
ELDN

PR Newswire

a year ago

Relmada Therapeutics Provides Corporate Update

Ur-Energy Inc. (TSE:URE) most popular amongst individual investors who own 49% of the shares, institutions hold 40%
ELDN

Simply Wall St.

a year ago

Ur-Energy Inc. (TSE:URE) most popular amongst individual investors who own 49% of the shares, institutions hold 40%

At US$20.32, Is It Time To Put Nu Skin Enterprises, Inc. (NYSE:NUS) On Your Watch List?
ELDN

Simply Wall St.

a year ago

At US$20.32, Is It Time To Put Nu Skin Enterprises, Inc. (NYSE:NUS) On Your Watch List?

Why QuickLogic (QUIK) Dipped More Than Broader Market Today
ELDN

Zacks

a year ago

Why QuickLogic (QUIK) Dipped More Than Broader Market Today

2024 election: $16B expected to be spent on political ads
ELDN

Yahoo Finance Video

a year ago

2024 election: $16B expected to be spent on political ads

Will Eledon Pharmaceuticals (NASDAQ:ELDN) Spend Its Cash Wisely?
ELDN

Simply Wall St.

a year ago

Will Eledon Pharmaceuticals (NASDAQ:ELDN) Spend Its Cash Wisely?

Alpha Teknova Insiders Land Bargain With Gains Of US$1.4m
ELDN

Simply Wall St.

a year ago

Alpha Teknova Insiders Land Bargain With Gains Of US$1.4m

The Zacks Analyst Blog Highlights Enanta, OneConnect Financial, KNOT Offshore, Hippo Holdings and H World
ELDN

Zacks

a year ago

The Zacks Analyst Blog Highlights Enanta, OneConnect Financial, KNOT Offshore, Hippo Holdings and H World

Sidoti Events, LLC's Virtual December Small-Cap Conference
ELDN

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

AMREP Corporation's (NYSE:AXR) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
ELDN

Simply Wall St.

a year ago

AMREP Corporation's (NYSE:AXR) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Pixelworks Empowers OnePlus 12 Smartphone to Deliver a Fully Immersive Gaming Experience
ELDN

PR Newswire

a year ago

Pixelworks Empowers OnePlus 12 Smartphone to Deliver a Fully Immersive Gaming Experience

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ELDN

GlobeNewswire

a year ago

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Citi Trends, Inc. (NASDAQ:CTRN) Q3 2023 Earnings Call Transcript
ELDN

Insider Monkey

a year ago

Citi Trends, Inc. (NASDAQ:CTRN) Q3 2023 Earnings Call Transcript

111, Inc. (NASDAQ:YI) Q3 2023 Earnings Call Transcript
ELDN

Insider Monkey

a year ago

111, Inc. (NASDAQ:YI) Q3 2023 Earnings Call Transcript

Sangoma Technologies Partnership Powers UK PSTN Switch-Off Opportunities
ELDN

Business Wire

a year ago

Sangoma Technologies Partnership Powers UK PSTN Switch-Off Opportunities

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
ELDN

GlobeNewswire

a year ago

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference

Tata Advanced Systems and Satellogic Sign Strategic Contract to Build LEO Satellites in India
ELDN

Business Wire

a year ago

Tata Advanced Systems and Satellogic Sign Strategic Contract to Build LEO Satellites in India

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND
ELDN

GlobeNewswire

a year ago

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND

Aemetis, Inc. (NASDAQ:AMTX) Q3 2023 Earnings Call Transcript
ELDN

Insider Monkey

a year ago

Aemetis, Inc. (NASDAQ:AMTX) Q3 2023 Earnings Call Transcript

WESTERN COPPER AND GOLD PROVIDES GUIDANCE ON ENVIRONMENTAL AND SOCIO-ECONOMIC EFFECTS STATEMENT SUBMISSION AND INFRASTRUCTURE UPDATE
ELDN

CNW Group

a year ago

WESTERN COPPER AND GOLD PROVIDES GUIDANCE ON ENVIRONMENTAL AND SOCIO-ECONOMIC EFFECTS STATEMENT SUBMISSION AND INFRASTRUCTURE UPDATE

Ecofin Sustainable and Social Impact Term Fund (TEAF) Announces its Upcoming Monthly Distributions
ELDN

ACCESSWIRE

a year ago

Ecofin Sustainable and Social Impact Term Fund (TEAF) Announces its Upcoming Monthly Distributions

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
ELDN

GlobeNewswire

a year ago

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

Largo Reports Third Quarter 2023 Financial Results; Announces First Commercial Shipment of Ilmenite as By-Product of its Vanadium Operations in Brazil and Validation of its 6 MWh Vanadium Redox Flow Battery to Operate on Test Conditions in Spain
ELDN

Business Wire

2 years ago

Largo Reports Third Quarter 2023 Financial Results; Announces First Commercial Shipment of Ilmenite as By-Product of its Vanadium Operations in Brazil and Validation of its 6 MWh Vanadium Redox Flow Battery to Operate on Test Conditions in Spain

ELDN

Associated Press Finance

2 years ago

Assembly Biosciences: Q3 Earnings Snapshot

Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference
ELDN

GlobeNewswire

2 years ago

Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference

Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
ELDN

GlobeNewswire

2 years ago

Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates

Allot (NASDAQ:ALLT shareholders incur further losses as stock declines 14% this week, taking three-year losses to 84%
ELDN

Simply Wall St.

2 years ago

Allot (NASDAQ:ALLT shareholders incur further losses as stock declines 14% this week, taking three-year losses to 84%

Sonida Senior Living Names Tabitha Obenour Chief Clinical Officer
ELDN

Business Wire

2 years ago

Sonida Senior Living Names Tabitha Obenour Chief Clinical Officer

Network-1 Reports Third Quarter Results
ELDN

ACCESSWIRE

2 years ago

Network-1 Reports Third Quarter Results

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
ELDN

GlobeNewswire

2 years ago

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Share on Social Networks: